University of California gains ground after EPO backs CRISPR patent

In a victory for the University of California, the European Patent Office (EPO) has affirmed a CRISPR patent issued to Emmanuelle Charpentier, the University of California, and the University of Vienna.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Wisconsin uni to pay $32 million for withholding Zemplar royalties

29 October 2020 St. Louis-based Washington University has won more than $31.6 million from a patent victory over the University of Wisconsin’s technology transfer office.

Americas

CareDx drops transplant testing patent suit

3 September 2020 California-based molecular diagnostics company CareDx and Stanford University have dropped their patent infringement suit against Tai Diagnostics, nearly five months after filing the complaint.

Europe

Breaking: EPO revokes Broad’s CRISPR patent

16 January 2020 In a dramatic reversal, a European Patent Office’s board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent.